APDN Applied DNA Sciences Inc

Applied DNA Sciences, Inc. (OTCBB: APDN), (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, announced today that it will present at the annual Security Investor Conference, sponsored by Imperial Capital. The Conference has grown to become the security sector's premier event, attracting, among others, institutional investors, including public or private equity or debt investment funds, government and DHS representatives.

Attendees are invited to hear Applied DNA Sciences CEO and President James A., Hayward speak on Thursday, December 13 at 3:15 PM. A recording of Dr. Hayward's presentation will be available on line beginning immediately after the presentation, at this link.

Individual meetings with Dr. Hayward and other APDN representatives may be arranged before or during the conference by contacting event organizers. Please see the Conference website for further information about one to one meetings.

The Conference is by invitation only, and runs from Wednesday, December 12 through December 13 in New York.

Highlighting the Defense Logistics Agency mandate requiring use of APDN DNA marking on certain parts provided to the military, the "Security Industry Monitor," published by event sponsor Imperial Capital, advised its investors that APDN "continues to be well-positioned in (the) potentially larger market (of microelectronic circuits)."

Dr. James A. Hayward commented,

"We are honored by the invitation to present at Imperial's prestigious Security Investors Conference. It is an opportunity to explain to investors our newest advances, in the military anti-counterfeiting sector, in cash in transit where we have recently expanded into Sweden, and with newer technologies such as our digitalDNA track and trace solution. We believe we will give investors a lot to think about."

About Applied DNA Sciences

APDN is a provider of botanical-DNA based security and authentication solutions that can help protect products, brands and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature® DNA and smartDNA, our principal anti-counterfeiting and product authentication solutions that essentially cannot be copied, provide a forensic chain of evidence and can be used to prosecute perpetrators.

The statements made by APDN may be forward-looking in nature. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K, filed on December 8, 2011 and our subsequent quarterly reports on Form 10-Q. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.

MEDIA CONTACT: Mitchell Miller 646-543-3373 fax: 631-444-8848 INVESTOR CONTACT: Debbie Bailey 631-444-8090 fax: 631-444-8848 FCMN Contact: Email Contact Web site: http://www.adnas.com Twitter: @APDN, @APDNInvestor